The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...

The two companies have entered into a strategic partnership to exclusively commercialize Braile’s Transcatheter Aortic Valve Implantation (TAVI) technology across Europe, India, and other ...

Adding Farxiga (dapagliflozin) to standard care significantly reduced the risk of death or worsening heart failure in older patients with severe aortic stenosis following transcatheter aortic-valve ...

People with a certain heart valve abnormality are at increased risk ... The researchers are now continuing to study scarring in the heart using MRI (magnetic resonance imaging) and analyse tissue ...

The company is looking to TMTT to support sales growth at a time when the larger transcatheter aortic valve replacement business has slowed. BTIG analysts are predicting TAVR sales will grow 3% in the ...

For over a decade, the McGill University Health Centre (MUHC) has been at the forefront of aortic valve innovation, advancing how we treat cardiac patients through minimally invasive approaches. That ...

This prospective cohort‐study included adult patients undergoing aortic valve surgery or ascending aortic surgery at a single center (2007–2013). The primary outcome was aortic diameter growth; ...

Take a look: Axis Bank maintains its bullish trajectory ... northward journey towards ₹1,540- ₹1,565 levels in the short term. Volumes are gradually rising, indicating increased participation ...